Loading IOVA...
Iovance Biotherapeutics Inc.IOVAAs of 31 July 2026
Core fundamentals vs overall market
Forward 3-year CAGR·
Gross margin (TTM)·
Net margin (TTM)·
Forward net margin·
−300−1500+150+300
53
PositiveNegative
Equilibrium
CheapExpensive
Emotion−48
FearGreed
WeakStrong
Fundamentals

How strong are Iovance Biotherapeutics Inc.'s fundamentals?

A read on the fundamental strength of Iovance Biotherapeutics Inc. (IOVA): whether the business underneath the share price is sound or deteriorating, so a low valuation reads as a real opportunity rather than a value trap. Information, not advice.

Iovance Biotherapeutics Inc.IOVALast 5 years
VEFA
IOVA priceasymmetryquant.com